This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active ulcerative colitis (UC). The primary goal of the study is to assess the efficacy and safety of multiple interventions following intravenous (IV) induction and subcutaneous (SC) maintenance treatment. Register Today!
EFC18326 – Crohn’s
EFC18325 – Ulcerative Colitis
SPY123-201- Ulcerative Colitis
Read More
IMG-007-203 – Atopic Dermatitis
This Phase 2a study is the first to evaluate safety and efficacy of a non-depleting OX40 mAb in moderate-to-severe AD patients. The objective is to demonstrate that blocking OX40 without depleting T cells results in good clinical safety and efficacy. Register Today!
Isabelle Chevrier
About Isabelle Isabelle earned a Master’s degree in Forensic Chemistry and Toxicology from Laurentian University in 2024. Born and raised in Greater Sudbury, Isabelle is excited to pursue the avenues of clinical research in her hometown as a bilingual clinical research coordinator. Outside of work, Isabelle enjoys playing sports, traveling, and spending time with her…
M24-885
This Phase 2a proof of concept (PoC) study is a 24-week Induction and Maintenance Period and a 72-week Long-Term Extension Period treat-through design study that utilizes a platform framework. The study will evaluate the clinical efficacy and safety of targeted therapies (TaTs) in moderate to severe CD. For the purpose of this protocol, TaTs represent…
222253
A Phase 3b, open-label study to evaluate the non-inferiority of the immune response and to evaluate the safety of the RSVPreF3 OA investigational vaccine in adults 18-49 years of age at increased risk for respiratory syncytial virus disease, compared to older adults ≥60 years of age. Register Today!
Oguzhan Serce
About Oguzhan Oguzhan Serce is an experienced Clinical Research Coordinator with a strong background in molecular biology and clinical trials. He holds a Master of Health Science in Anatomy from Mersin University and a Bachelor of Science in Molecular Biology and Genetics from Istanbul Technical University. He began his career in clinical research focusing on…
Dr. Melanie Langille
About Dr. Langille Dr. Melanie Langille is a NOSM University alumna working as a bilingual hospitalist physician at Health Sciences North and palliative care physician at Maison McCulloch Hospice. Dr. Langille is also an Assistant Professor at NOSM University and is the Health Sciences North Hospitalist Clinical Educator Lead. She has global health experience that…